TAVI Cost-Effectiveness in Brazil: Balancing Co...

By Staff Writer

August 21, 2025

The focus on TAVI cost-effectiveness Brazil has gained attention. The country is assessing the expansion of coverage for transcatheter aortic valve implantation (TAVI). This would include patients with severe aortic stenosis who are classified as ...
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Rare Medications Coverage in the Netherlands: Price Reductions Required
Enhancing Benefit Assessments: Insights from IQWiG Real-World Data Report
Dutch Pharmacoeconomic Redesign: Streamlined Structure and Enhanced Transpare...
Global Health Technology Assessment: Navigating NICE’s Role and Challen...
Revolutionizing Pharmacoeconomic Evaluations Nederland: Zorginstituut’s...
Model Type and Its Impact on Pneumococcal Vaccine Cost-Effectiveness in Germany
NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patie...
Talquetamab Multiple Myeloma: Impact, Evidence, and Policy Considerations
10-Year Health Plan: Transforming England’s NHS for the Future